
Dr. P. Jagannath
Chairman — Department of Surgical Oncology, Lilavati Hospital & Research Centre
Experience
45 years
Rating
4.8 (290 reviews)
Languages
English, Hindi, Marathi, Kannada
Location
Mumbai, India
About the doctor
Dr. P. Jagannath chairs Surgical Oncology at Lilavati Hospital Mumbai and is regarded as one of India's most experienced hepato-pancreatico-biliary cancer surgeons with 45 years in the field. His personal series includes 4,500+ liver and pancreatic cancer surgeries. He trained at the Tata Memorial Hospital (MCh Surgical Oncology) and at Memorial Sloan Kettering Cancer Center, New York, and has held Visiting Professor appointments at MSKCC and Mayo Clinic. Founder of the Indian Society of Surgical Oncology, he is past President of the Indian Association of Surgical Oncology and the Asian Hepato-Biliary Pancreatic Association, and is editor of the standard textbook 'GI Surgical Oncology' used across Indian medical colleges.
Areas of expertise
Oncology planning and specialist review
Case evaluation for patients exploring treatment in India
Treatment pathway discussion with hospital coordination
International patient support and next-step guidance
How Livance supports patients here
International patient support
Treatment-pathway guidance
Hospital coordination support
Structured follow-up communication
Consultation journey
Share reports and diagnosis
Receive specialist pathway guidance
Discuss treatment and hospital options
Plan travel and next steps
Associated hospital
Mumbai, India
Related treatments
Kidney Cancer Treatment
Kidney Cancer Treatment in India is chosen by patients looking for quality specialty care, clearer treatment planning and better cost visibility. Livance helps patients understand how kidney cancer treatment is typically evaluated, what treatment pathways may be considered, what affects cost, and how to prepare for hospital stay, attendants and recovery support.
Open treatmentPancreatic Cancer Treatment
Pancreatic Cancer Treatment in India is chosen by patients looking for quality specialty care, clearer treatment planning and better cost visibility. Livance helps patients understand how pancreatic cancer treatment is typically evaluated, what treatment pathways may be considered, what affects cost, and how to prepare for hospital stay, attendants and recovery support.
Open treatmentProstate Cancer Treatment
Prostate Cancer Treatment in India is chosen by patients looking for quality specialty care, clearer treatment planning and better cost visibility. Livance helps patients understand how prostate cancer treatment is typically evaluated, what treatment pathways may be considered, what affects cost, and how to prepare for hospital stay, attendants and recovery support.
Open treatmentColorectal Cancer Treatment
Colorectal Cancer Treatment in India is chosen by patients looking for quality specialty care, clearer treatment planning and better cost visibility. Livance helps patients understand how colorectal cancer treatment is typically evaluated, what treatment pathways may be considered, what affects cost, and how to prepare for hospital stay, attendants and recovery support.
Open treatmentLiver Cancer Treatment
Liver Cancer Treatment in India is chosen by patients looking for quality specialty care, clearer treatment planning and better cost visibility. Livance helps patients understand how liver cancer treatment is typically evaluated, what treatment pathways may be considered, what affects cost, and how to prepare for hospital stay, attendants and recovery support.
Open treatmentFrequently asked questions
What does Dr. P. Jagannath specialize in?
Dr. P. Jagannath focuses on oncology and supports patients who need clear treatment planning and specialist guidance.
Can Livance help patients connect with this doctor?
Yes. Livance can help organize the next step, treatment planning discussion, and hospital matching around this specialty.
What should patients share before consultation?
It helps to share diagnosis details, scans, reports, current treatment advice and travel timeline before speaking to the team.